People | May 11, 2026
Symeres appoints Henning Steinhagen as CEO to drive next phase of global growth
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
Expands manufacturing push & locks in major growth deals
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Lifts full-year outlook as obesity drug boom accelerates
But acquisition charges drag earnings into loss
The company posted revenue of €1,267 million, up 6% on a constant currency basis
Subscribe To Our Newsletter & Stay Updated
